Bulk Manufacturer of Controlled Substances Registration, 3251 [2019-01862]
Download as PDF
<![CDATA[
3251
Federal Register / Vol. 84, No. 28 / Monday, February 11, 2019 / Notices
Comments and requests for hearing on
applications to import narcotic raw
material are not appropriate. 72 FR 3417
(January 25, 2007).
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR
1301.34(a), this is notice that on
December 6, 2018, Stepan Company,
100 West Hunter Avenue, Maywood,
New Jersey 07607–1021 applied to be
registered as an importer of the
following basic class of controlled
substance:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Registration
ACTION:
Controlled
substance
Drug
code
Coca Leaves ............
9040
Schedule
II
The company plans to import the
listed controlled substance in bulk for
the manufacture of controlled
substances for distribution to its
customers.
Dated: February 4, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–01847 Filed 2–8–19; 8:45 am]
BILLING CODE 4410–09–P
Notice of registration.
The registrant listed below
has applied for and been granted a
registration by the Drug Enforcement
Administration (DEA) as bulk
manufacturer of a schedule I controlled
substance.
SUPPLEMENTARY INFORMATION: The
company listed below applied to be
registered as a bulk manufacturer of a
various basic class of a schedule I
controlled substance. Information on the
previously published notice is listed in
the table below. No comments or
objections were submitted for this
notice.
SUMMARY:
Company
FR Docket
Specgx, LLC .....................................................................................................................................................
83 FR 51983
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of this registrant to
manufacture the applicable basic class
of controlled substance is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the DEA has granted a
registration as a bulk manufacturer to
the above listed company.
Dated: January 30, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–01862 Filed 2–8–19; 8:45 am]
BILLING CODE 4410–09–P
VerDate Sep<11>2014
18:05 Feb 08, 2019
Jkt 247001
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 19–2]
Paul Surinder Singh, D.O.; Decision
And Order
On August 8, 2018, the Assistant
Administrator, Diversion Control
Division, Drug Enforcement
Administration (DEA), issued an Order
to Show Cause to Paul Surinder Singh,
D.O. (Respondent), of Tehachapi,
California. The Show Cause Order
proposed the revocation of
Respondent’s DEA Certificate of
Registration No. BS7367623 on the
ground that he has ‘‘no state authority
to handle controlled substances.’’ Order
to Show Cause, at 1 (citing 21 U.S.C.
824(a)(3)). For the same reason, the
Order also proposed the denial of any of
Respondent’s ‘‘applications for renewal
or modification of such registration and
any applications for any other DEA
registrations.’’ Id.
With respect to the Agency’s
jurisdiction, the Show Cause Order
alleged that Respondent is the holder of
Certificate of Registration No.
BS7367623, pursuant to which he is
authorized to dispense controlled
substances as a practitioner in schedules
II through V, at the registered address of
276 C South Mill Street, Tehachapi,
California. Id. The Order also alleged
PO 00000
Frm 00115
Fmt 4703
Sfmt 4703
Published
October 15, 2018.
that this registration does not expire
until February 28, 2019. Id.
Regarding the substantive grounds for
the proceeding, the Show Cause Order
alleged that on April 17, 2017, the
Osteopathic Medical Board of California
(OMBC) ‘‘adopted the Proposed
Decision of an Administrative Law
Judge . . . recommending revocation
of’’ Respondent’s ‘‘Osteopathic
Physician’s License,’’ effective on May
17, 2017. Id. As a result, the Order
alleged that Respondent is ‘‘without
authority to handle controlled
substances in the State of California, the
[S]tate in which [he is] registered with
DEA.’’ Id. at 1–2. Based on his ‘‘lack of
authority to [dispense] controlled
substances in . . . California,’’ the
Order asserted that ‘‘DEA must revoke’’
Respondent’s registration. Id. at 2 (citing
21 U.S.C. 824(a)(3); 21 CFR 1301.37(b)).
The Show Cause Order notified
Respondent of (1) his right to request a
hearing on the allegations or to submit
a written statement in lieu of a hearing,
(2) the procedure for electing either
option, and (3) the consequence for
failing to elect either option. Id. (citing
21 CFR 1301.43). The Order also
notified Respondent of his right to
submit a corrective action plan. Id. at
2–3 (citing 21 U.S.C. 824(c)(2)(C)).
On October 15, 2018, Respondent
filed a letter (dated October 9, 2018)
indicating that the Show Cause Order
was ‘‘delivered to [him] by DEA agents
E:\FR\FM\11FEN1.SGM
11FEN1
]]>Agencies
[Federal Register Volume 84, Number 28 (Monday, February 11, 2019)]
[Notices]
[Page 3251]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01862]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Registration
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: The registrant listed below has applied for and been granted a
registration by the Drug Enforcement Administration (DEA) as bulk
manufacturer of a schedule I controlled substance.
SUPPLEMENTARY INFORMATION: The company listed below applied to be
registered as a bulk manufacturer of a various basic class of a
schedule I controlled substance. Information on the previously
published notice is listed in the table below. No comments or
objections were submitted for this notice.
----------------------------------------------------------------------------------------------------------------
Company FR Docket Published
----------------------------------------------------------------------------------------------------------------
Specgx, LLC....................................... 83 FR 51983.............. October 15, 2018.
----------------------------------------------------------------------------------------------------------------
The DEA has considered the factors in 21 U.S.C. 823(a) and
determined that the registration of this registrant to manufacture the
applicable basic class of controlled substance is consistent with the
public interest and with United States obligations under international
treaties, conventions, or protocols in effect on May 1, 1971. The DEA
investigated the company's maintenance of effective controls against
diversion by inspecting and testing the company's physical security
systems, verifying the company's compliance with state and local laws,
and reviewing the company's background and history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21
CFR 1301.33, the DEA has granted a registration as a bulk manufacturer
to the above listed company.
Dated: January 30, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-01862 Filed 2-8-19; 8:45 am]
BILLING CODE 4410-09-P
